当前位置: 首页 > 详情页

Long-term outcome of endovascular therapy for acute basilar artery occlusion

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology and China-America Institute ofNeuroscience, Capital Medical University, Beijing, China [2]Department of Radiology, Beth Israel Deaconess Medical Center,Boston, MA, USA [3]Department of Neurosurgery, Capital Medical University, Beijing, China [4]Department of Emergency, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Basilar artery occlusion endovascular therapy long-term outcome prognostic factor stroke

摘要:
The long-term functional outcome of acute basilar artery occlusion (BAO) patients who received modern endovascular therapy (EVT) is unclear. We sought to assess the long-term functional outcome of BAO patients treated with EVT and determine the prognostic factors associated with favorable outcome. We enrolled consecutive BAO patients who received EVT between December 2012 and December 2018 in this observational study. Baseline characteristics and outcomes were presented. Multivariable logistic regression analysis was performed to identify the prognostic factors associated with long-term outcome. Among the 177 BAO patients included in this study, 80 patients (45.2%) obtained favorable outcome and 97 patients (54.8%) had unfavorable outcome at long-term follow-up with a median observation time of 12 months (interquartile range, 3-19). A total of 67 patients (37.9%) died. National Institutes of Health Stroke Scale (NIHSS), posterior circulation Alberta Stroke Program Early Computed Tomography Score (pc-ASPECTS), time from stroke onset to recanalization, and recanalization condition were identified as independent predictors for long-term outcome. Over 40% of BAO patients who were treated with modern EVT achieved favorable outcome at long-term follow-up. NIHSS, pc-ASPECTS, time from stroke onset to recanalization, and recanalization condition were identified as independent prognostic factors of long-term outcome.

基金:

基金编号: 2016YFC1301502 2017YFC1308401 81771260 81601006 81620108011

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢 2 区 血液学 2 区 神经科学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢 2 区 血液学 2 区 神经科学
JCR分区:
出版当年[2019]版:
Q1 ENDOCRINOLOGY & METABOLISM Q1 NEUROSCIENCES Q1 HEMATOLOGY
最新[2023]版:
Q1 ENDOCRINOLOGY & METABOLISM Q1 HEMATOLOGY Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Neurology and China-America Institute ofNeuroscience, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [*1]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院